Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vathany Kulasingam

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Cancer Cytopathology|August 29, 2023
Role of EBUS-TBNA/EUS-FNA and mass spectrometry for diagnosis and typing of lymph node amyloidosis: 10-year experience in two tertiary care academic centersAsghar Naqvi, Michael Bonert, Christian Finley, et al.
Clinical Biochemistry|May 27, 2010
Pediatric reference intervals for 28 chemistries and immunoassays on the Roche cobas 6000 analyzer--a CALIPER pilot studyVathany Kulasingam, Benjamin P Jung, Ivan M Blasutig, et al.
Journal of Clinical Laboratory Analysis|July 15, 2022
Multi-center evaluation of the highly sensitive Abbott ARCHITECT and Alinity thyroglobulin chemiluminescent microparticle immunoassayCarol Evans, Johannes Lotz, Maria Bhandari, et al.
The Journal of Infectious Diseases|November 5, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Infection Induces Greater T-Cell Responses Compared to Vaccination in Solid Organ Transplant RecipientsVictor H Ferreira, Tina Marinelli, Matthew Ierullo, et al.
Clinical Proteomics|July 2, 2014
Deciphering the peptidome of urine from ovarian cancer patients and healthy controlsChristopher R Smith, Ihor Batruch, Josep Miquel Bauça, et al.
Clinical Chemistry|September 29, 2016
The Use of Targeted Therapies for Precision Medicine in OncologyNicole White Al-Habeeb, Vathany Kulasingam, Eleftherios P Diamandis, et al.
Clinical Chemistry and Laboratory Medicine|November 16, 2022
Mucin 13 (MUC13) as a candidate biomarker for ovarian cancer detection: potential to complement CA125 in detecting non-serous subtypesAnnie H Ren, Panagiota S Filippou, Antoninus Soosaipillai, et al.
Nature Immunology|February 4, 2022
Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responsesVictoria G Hall, Victor H Ferreira, Heidi Wood, et al.
Clinical Chemistry|October 8, 2013
False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125Ioannis Prassas, Davor Brinc, Sofia Farkona, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 4, 2021
Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipientsVictoria G Hall, Victor H Ferreira, Matthew Ierullo, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Cancer Cytopathology|August 29, 2023
Role of EBUS-TBNA/EUS-FNA and mass spectrometry for diagnosis and typing of lymph node amyloidosis: 10-year experience in two tertiary care academic centersAsghar Naqvi, Michael Bonert, Christian Finley, et al.
Clinical Biochemistry|May 27, 2010
Pediatric reference intervals for 28 chemistries and immunoassays on the Roche cobas 6000 analyzer--a CALIPER pilot studyVathany Kulasingam, Benjamin P Jung, Ivan M Blasutig, et al.
Journal of Clinical Laboratory Analysis|July 15, 2022
Multi-center evaluation of the highly sensitive Abbott ARCHITECT and Alinity thyroglobulin chemiluminescent microparticle immunoassayCarol Evans, Johannes Lotz, Maria Bhandari, et al.
The Journal of Infectious Diseases|November 5, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Infection Induces Greater T-Cell Responses Compared to Vaccination in Solid Organ Transplant RecipientsVictor H Ferreira, Tina Marinelli, Matthew Ierullo, et al.
Clinical Proteomics|July 2, 2014
Deciphering the peptidome of urine from ovarian cancer patients and healthy controlsChristopher R Smith, Ihor Batruch, Josep Miquel Bauça, et al.
Clinical Chemistry|September 29, 2016
The Use of Targeted Therapies for Precision Medicine in OncologyNicole White Al-Habeeb, Vathany Kulasingam, Eleftherios P Diamandis, et al.
Clinical Chemistry and Laboratory Medicine|November 16, 2022
Mucin 13 (MUC13) as a candidate biomarker for ovarian cancer detection: potential to complement CA125 in detecting non-serous subtypesAnnie H Ren, Panagiota S Filippou, Antoninus Soosaipillai, et al.
Nature Immunology|February 4, 2022
Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responsesVictoria G Hall, Victor H Ferreira, Heidi Wood, et al.
Clinical Chemistry|October 8, 2013
False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125Ioannis Prassas, Davor Brinc, Sofia Farkona, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 4, 2021
Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipientsVictoria G Hall, Victor H Ferreira, Matthew Ierullo, et al.
Pageof 11